康哲药业根据相关协议,已获得Vecantoxatug和Silevimig注射液在中国大陆等地区的独家商业化权利。
康哲药业根据相关协议,已获得Vecantoxatug和Silevimig注射液在中国大陆等地区的独家商业化权利。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.